Literature DB >> 12037026

Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.

M A E Nobbenhuis1, T J M Helmerhorst, A J C van den Brule, L Rozendaal, L H Jaspars, F J Voorhorst, R H M Verheijen, C J L M Meijer.   

Abstract

BACKGROUND/AIMS: Self sampling is considered an adjuvant tool to facilitate the participation of women in cervical cancer screening programmes. This study aimed to evaluate whether cervicovaginal lavage could be an alternative for the cervical smear in cytology and human papillomavirus (HPV) testing and to assess the acceptance of the self sampling device by women.
METHODS: Fifty six women with abnormal cervical cytology (very mild dyskaryosis or worse) and 15 women with normal cervical cytology obtained a self collected cervicovaginal lavage at home and filled in a questionnaire on the use of the device. At the colposcopy clinic the gynaecologist performed the same procedure followed by a cervical smear for cytology and HPV DNA testing.
RESULTS: The self sampling device was acceptable to 88% of the women. The concordance between the cytology results in the smear and the lavage by the doctor and the patient was 54% and 41%, respectively (kappa = 0.28 and 0.14). The concordance between high risk HPV detection in the smear and the lavage by the doctor and the patient was 93% and 78%, respectively (kappa = 0.82 and 0.53). Ninety one per cent of the women with high grade cervical intraepithelial neoplasia (CIN) had a high risk HPV positive test in the smear, compared with 91% and 81% in the lavages taken by the doctor and the patient, respectively.
CONCLUSIONS: HPV DNA testing by home obtained samples is useful as a screening tool for cervical cancer, whereas cervical cytology by self sampling is not. Although the sensitivity for high grade CIN by high risk HPV testing in the lavage by the patient is not significantly lower than that in the cervical smear, self sampling for HPV DNA is a feasible alternative method in women who decline to participate in population based cervical cancer screening programmes. However, participation in the screening programme remains the best option.

Entities:  

Mesh:

Year:  2002        PMID: 12037026      PMCID: PMC1769675          DOI: 10.1136/jcp.55.6.435

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  The effectiveness of cervical screening: a population-based case-control study.

Authors:  Y van der Graaf; G A Zielhuis; P G Peer; P G Vooijs
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

2.  Screening for cervical neoplasia by self-assessment for human papillomavirus DNA.

Authors:  P Hillemanns; R Kimmig; U Hüttemann; C Dannecker; C J Thaler
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

3.  [Recommendations in aberrant findings of cytological studies of the cervix uteri].

Authors:  G P Vooijs
Journal:  Ned Tijdschr Geneeskd       Date:  1987-09-19

4.  Inexpensive population screening for abnormal cells from the uterine cervix and valid results using the vaginal cytopipette.

Authors:  S Fischer
Journal:  Gynecol Oncol       Date:  1992-07       Impact factor: 5.482

5.  PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.

Authors:  L Rozendaal; J M Walboomers; J C van der Linden; F J Voorhorst; P Kenemans; T J Helmerhorst; M van Ballegooijen; C J Meijer
Journal:  Int J Cancer       Date:  1996-12-11       Impact factor: 7.396

6.  Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

Authors:  J W Sellors; A T Lorincz; J B Mahony; I Mielzynska; A Lytwyn; P Roth; M Howard; S Chong; D Daya; W Chapman; M Chernesky
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

7.  PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes.

Authors:  L Rozendaal; J Westerga; J C van der Linden; J M Walboomers; F J Voorhorst; E K Risse; M E Boon; C J Meijer
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

8.  Self-administered home cervicovaginal lavage: a novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections.

Authors:  E A Morrison; G L Goldberg; R J Hagan; A S Kadish; R D Burk
Journal:  Am J Obstet Gynecol       Date:  1992-07       Impact factor: 8.661

Review 9.  The Papanicolaou test for cervical cancer detection. A triumph and a tragedy.

Authors:  L G Koss
Journal:  JAMA       Date:  1989-02-03       Impact factor: 56.272

10.  A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.

Authors:  M V Jacobs; D Zielinski; C J Meijer; R P Pol; F J Voorhorst; F A de Schipper; A P Runsink; P J Snijders; J M Walboomers
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  30 in total

1.  Cervical cancer.

Authors:  P J van Diest; H Holzel
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

2.  Self testing for human papillomaviruses.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

3.  Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years.

Authors:  Yvonne Deleré; Melanie Schuster; Elena Vartazarowa; Thomas Hänsel; Ingke Hagemann; Simone Borchardt; Heike Perlitz; Achim Schneider; Sabine Reiter; Andreas M Kaufmann
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

4.  Feasibility of collecting self-sampled vaginal swabs by mail: quantity and quality of genomic DNA.

Authors:  M F D Baay; V Verhoeven; H A J Lambrechts; G G O Pattyn; F Lardon; P Van Royen; J B Vermorken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-07-15       Impact factor: 3.267

5.  The indicating FTA elute cartridge a solid sample carrier to detect high-risk HPV and high-grade cervical lesions.

Authors:  Roosmarie P de Bie; Channa E Schmeink; Judith M J E Bakkers; Peter J F Snijders; Wim G V Quint; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

6.  Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.

Authors:  Akhila Balasubramanian; Shalini L Kulasingam; Atar Baer; James P Hughes; Evan R Myers; Constance Mao; Nancy B Kiviat; Laura A Koutsky
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

7.  Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.

Authors:  Richard A Crosby; Michael E Hagensee; Robin Vanderpool; Nia Nelson; Adam Parrish; Tom Collins; Nebraska Jones
Journal:  Sex Transm Dis       Date:  2015-11       Impact factor: 2.830

8.  High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush.

Authors:  Antoinette A T P Brink; Chris J L M Meijer; Maarten A H M Wiegerinck; Thedoor E Nieboer; Roy F P M Kruitwagen; Folkert van Kemenade; Nathalie Fransen Daalmeijer; Albertus T Hesselink; Johannes Berkhof; Peter J F Snijders
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

9.  Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples.

Authors:  Scott A Churchman; John A Moss; Marc M Baum
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-03-02       Impact factor: 3.205

10.  Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?

Authors:  Neerja Bhatla; Lalit Dar; A Rajkumar Patro; Pankaj Kumar; Alka Kriplani; Arti Gulati; Venkateswaran K Iyer; Sandeep R Mathur; Vishnubhatla Sreenivas; Keerti V Shah; Patti E Gravitt
Journal:  Cancer Epidemiol       Date:  2009-11-20       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.